199 related articles for article (PubMed ID: 34621132)
1. The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma.
Zheng Z; Yang C; Cai C; Zhu H
Cancer Manag Res; 2021; 13():7511-7516. PubMed ID: 34621132
[TBL] [Abstract][Full Text] [Related]
2. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
Wang X; Wang Z; Lu WL; Zhao GF
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
[No Abstract] [Full Text] [Related]
3. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Chen QX
World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
5. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus.
Wang C; Tong J; Tang M; Lu Y; Liang G; Zhang Z; Chen T
Cancer Manag Res; 2021; 13():1075-1085. PubMed ID: 33574705
[TBL] [Abstract][Full Text] [Related]
7. Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy.
Chen LC; Li SH; Lo CM; Chen YH; Huang SC; Wang YM; Chou SY; Lu HI
J Thorac Dis; 2019 Nov; 11(11):4583-4590. PubMed ID: 31903247
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
[TBL] [Abstract][Full Text] [Related]
11. Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma.
Ye S; Bai L
Cancer Manag Res; 2018; 10():3405-3417. PubMed ID: 30237742
[TBL] [Abstract][Full Text] [Related]
12. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva?
Ertas IE; Gungorduk K; Akman L; Ozdemir A; Terek MC; Ozsaran A; Sanci M; Dikmen Y
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):138-42. PubMed ID: 23992992
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
Zhang Y; Jiang C; Li J; Sun J; Qu X
Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
[TBL] [Abstract][Full Text] [Related]
14. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
[TBL] [Abstract][Full Text] [Related]
15. Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
Yang Y; Tan H; Lu Y; Mei J; Zhang M; Bai M; Wang X; Ge S; Ning T; Zhang L; Ji Z; Duan J; Sun Y; Wang F; Liu R; Li H; Deng T
BMC Cancer; 2024 Feb; 24(1):249. PubMed ID: 38389042
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
18. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
Chen S; Guo J; Feng C; Ke Z; Chen L; Pan Y
Ther Adv Med Oncol; 2016 May; 8(3):160-7. PubMed ID: 27239234
[TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma.
Acharya S; Rai P; Hallikeri K; Anehosur V; Kale J
J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27157628
[TBL] [Abstract][Full Text] [Related]
20. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Liu JS
Onco Targets Ther; 2013; 6():1605-12. PubMed ID: 24403837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]